Pura Vida Investments, LLC Glaukos Corp Call Options Transaction History

Pura Vida Investments, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 13, 2024	BUY	$59.53 - $85.11 $10.6 Million - $15.2 Million	178,500 New	178,500 $14.2 Million
Q3 2020 Nov 16, 2020	BUY	$37.23 - $50.97 $3.72 Million - $5.1 Million	100,000 New	100,000 $4.95 Million
Q3 2019 Nov 14, 2019	SELL	$58.58 - $83.91 $3.81 Million - $5.45 Million	-65,000 Closed	0 $0
Q2 2019 Feb 12, 2021	BUY	$63.59 - $78.71 $4.09 Million - $5.06 Million	64,350 Added 9900.0%	65,000 $4.9 Million
Q2 2019 Aug 14, 2019	BUY	$63.59 - $78.71 $41,333 - $51,161	650 New	650 $114,000
Q3 2018 Nov 14, 2018	SELL	$38.13 - $68.37 $2.91 Million - $5.21 Million	-76,200 Closed	0 $0
Q2 2018 Feb 11, 2021	BUY	$27.62 - $44.51 $2.08 Million - $3.36 Million	75,438 Added 9900.0%	76,200 $3.1 Million
Q2 2018 Aug 14, 2018	BUY	$27.62 - $44.51 $21,046 - $33,916	762 New	762 $76,000

303

47M

75.3K

157K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.03B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.